|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: MEDICIS PHARMACEUTICAL CORP, 10-K, EX-23.1, 2000-09-28 |
Next: TRIDENT MICROSYSTEMS INC, 10-K, 2000-09-28 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-START> JUL-01-1999
<PERIOD-END> JUN-30-2000
<CASH> 152,270,780
<SECURITIES> 133,466,609
<RECEIVABLES> 37,354,092
<ALLOWANCES> 4,190,000
<INVENTORY> 10,001,731
<CURRENT-ASSETS> 351,288,152
<PP&E> 2,706,939
<DEPRECIATION> 947,993
<TOTAL-ASSETS> 495,339,555
<CURRENT-LIABILITIES> 38,986,601
<BONDS> 0
0
0
<COMMON> 412,888
<OTHER-SE> 437,026,361
<TOTAL-LIABILITY-AND-EQUITY> 495,339,555
<SALES> 139,099,152
<TOTAL-REVENUES> 139,099,152
<CGS> 25,911,579
<TOTAL-COSTS> 25,911,579
<OTHER-EXPENSES> 57,681,090
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (11,875,261)
<INCOME-PRETAX> 67,381,744
<INCOME-TAX> 24,387,562
<INCOME-CONTINUING> 42,994,182
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 42,994,182
<EPS-BASIC> 1.48
<EPS-DILUTED> 1.41
</TABLE>
|
|